INSTITUTE OF CELLULAR THERAPIES

 

 

 DENVAXTM

DENDRITIC CELL THERAPY

Customized Cell-based Cancer Immunotherapy 

  

INSTITUTE OF CELLULAR THERAPIES PVT.LTD.
J-3
Sector 41
Noida, UP 201303
India

ph: 91-120-2500111
fax: 91-120-4317902
alt: 91-120-2500195

info@dendriticcellresearch.com

Twitter

  • HOME
    • DISCOVERY OF DENDRITIC CELLS
  • DENVAX
  • DENVAX PROTOCOL
  • DENVAX FAQs
  • PATIENT INFORMATION
  • SUCCESS STORIES
  • PUBLICATIONS
  • CLINICAL TRIAL RESULT
  • ABOUT US
  • CONTACT US
    • ANTAH HEALTHCARE, MALAYSIA
  • PREVENTIVE VACCINE
    • ADULT STEM CELL TRANSPLANT

Antah Healthcare, Malaysia

 ANTAH HEALTHCARE GROUP- OUR PARTNERS IN MALAYSIA

A leading healthcare marketing and distribution firm in Malaysia, Antah Healthcare Group shall be marketing and distributing ICT product DENVAX- IN MALAYSIA to cancer patients situated in Malaysian region.

 

About Antah Healthcare Group 

 Antah HealthCare Group is one of the largest Malaysian owned healthcare marketing and distribution company in the country, with branch offices located at major cities nationwide. The company has more than 45 years of experience in the healthcare industry and is supported by various market leaders of their own expertise - from highly specialised operating theater equipment to delicate patient monitoring devices, and a wide range of premier pharmaceutical products.

 

 

 

Please click  the following link for delivery of customized dendritic cell therapy product 'Denvax' to cancer patients in Malaysian region

ANTAH HEALTH CARE GROUP

Antah HealthCare Group can be contacted at following address

Main Office No 3 Jalan 19/1

46300 Petaling Jaya

Selangor Darul Ehsan

Malaysia

Phone 6-03-7956 7677

Fax 6-0379567390

Email enquiry@ahcg.com.my

  Copyright Institute of Cellular Therapies Pvt. Ltd.

All rights reserved.

Last updated on 19 October, 2011

 

 

 

 

 

 

 

 

 

 

INSTITUTE OF CELLULAR THERAPIES PVT.LTD.
J-3
Sector 41
Noida, UP 201303
India

ph: 91-120-2500111
fax: 91-120-4317902
alt: 91-120-2500195

info@dendriticcellresearch.com

Twitter